GLP-1 use doubles as bariatric surgery declines by 25%A study by researchers at Brigham and Women's Hospital, in collaboration with researchers at Harvard TH Chan School of Public Health and...
GLP-1 use doubles as bariatric surgery declines by 25%A study by researchers at Brigham and Women's Hospital, in collaboration with researchers at Harvard TH Chan School of Public Health and...
Bariatric patients see post-surgical increase in earnings out to five yearsPatients who received bariatric surgery saw a sustained average increase in earnings from six months to five years after surgery among...
FDA grants De Novo approval for Distalmotion’s Dexter Surgical Robot for adult inguinal hernia repairDistalmotion has been granted De Novo approval by the FDA to market the Dexter Surgical Robot for adult inguinal hernia repair. This...
Semaglutide has positive effect in chronic kidney diseaseSemaglutide has a positive effect on patients with chronic kidney disease and obesity. By decreasing the amount of protein in urine, the...
GLP-1s: Second year cost of care is $4,200 higher for patients with obesityIndividuals without diabetes who newly started glucagon-like peptide-1 (GLP-1) agonist drugs for obesity experienced an average of $4,206...
Skeletal muscle health concerns with the rise of weight loss medicationsA commentary published in The Lancet journal highlights the critical importance of skeletal muscle mass in the context of medically...
GLP-1 use doubles as bariatric surgery declines by 25%A study by researchers at Brigham and Women's Hospital, in collaboration with researchers at Harvard TH Chan School of Public Health and...
SOUL trial: Oral semaglutide demonstrates a 14% reduction in risk of major adverse CV eventsHeadline results from the SOUL cardiovascular outcomes trial show the trial achieved its primary objective by demonstrating a...
GDF15 drug shows promise in preventing heart failure related to T2DMA new experimental anti-obesity drug, Growth Differentiation Factor 15 (GDF15), improves diastolic heart function in mice with type 2...
Allurion submits 1st of three PMA modules to FDAAllurion Technologies has submitted the first three modules of its premarket approval application (PMA) to the FDA for the Allurion...
Conversion from SG to Ring augmented RYGB is safe and effectiveThe first study to demonstrate the safety and effectiveness of a conversion from sleeve gastrectomy (SG) to a Ring-augmented Roux-en-Y...
FDA approves labelling update for VIVUS’ QSYMIAThe FDA has approved a labelling update for VIVUS’ QSYMIA (phentermine and topiramate extended-release capsules CIV) that has removed the...
Journal Watch 23/10/2024Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
FDA grants De Novo approval for Distalmotion’s Dexter Surgical Robot for adult inguinal hernia repair